rewirebio.iobenchmarks
Result

Percent agreement (vs expert reassessment) of Historical Erlangen MTB protein-function interpretation on MTB selected expert reassessment

34% Percent agreement (vs expert reassessment)

Methods

Tested configuration
Historical Erlangen MTB protein-function interpretation
Protocol
OncoVI three-class assessment: MTB selected expert reassessment
Dataset
MTB selected expert reassessment
Evaluation
Historical MTB agreement with expert oncogenicity reassessment
Coverage
Not reported scored / Not reported eligible
Uncertainty
Not reported by the source: not reported for this endpoint
Evidence
Author-reported evaluation · source checkedOncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, validation data set, paragraph ending 46/135; Figure 4A

A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.

Reproduction

Split
Not reported
Adaptation
Not reported
Scoring implementation
Source-defined endpoint; see result source_locator

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Reported result
34%
Individual claims
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

Results, validation data set, paragraph ending 46/135; Figure 4A

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

source checked

["automated-source-review"] · 2026-09-30

author reported

Audit details

Transcription from inspected primary source. No execution, independent replication or human scientific review.

Field: attributes.printed_value

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-clinical-20260930-oncovi-prior-mtb-expert-agreement

areas
dna-genomes
contexts
clinical_research
metric
percent-agreement
unit
percent
printed value
34%
numeric value
34
metric direction
higher
source locator
Results, validation data set, paragraph ending 46/135; Figure 4A
review
method: automated-source-review; reviewer: codex; date: 2026-09-30; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20260930-source-oncovi; reviewer note: role: clinical coverage worker
numerator
46
denominator
135
missing metadata
uncertainty: reason: unreported; note: not reported for this endpoint
metric qualifier
vs expert reassessment
Related records

Suggest a correction